{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T06:30:11Z","timestamp":1793946611802,"version":"4.8.0"},"reference-count":71,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100010870","name":"Qingdao Municipal Science and Technology Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010870","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.critrevonc.2026.105445","type":"journal-article","created":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T06:14:52Z","timestamp":1781936092000},"page":"105445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Oncolytic virus-based immunotherapy for hepatocellular carcinoma: Strategies for enhanced efficacy and clinical application"],"prefix":"10.1016","volume":"226","author":[{"given":"Jintan","family":"Xiao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-0303-5054","authenticated-orcid":false,"given":"Peng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.critrevonc.2026.105445_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/v17010016","article-title":"Employing the oncolytic vesicular stomatitis virus in cancer virotherapy: resistance and clinical considerations","volume":"17","author":"Abdelmageed","year":"2024","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105445_bib2","doi-asserted-by":"crossref","DOI":"10.1063\/5.0092330","article-title":"Nanoformulation of intelligence polymeric nanocarrier for resveratrol targeted delivery and study its cytotoxic, apoptotic, and genetics effects in epidermoid carcinoma therapy","volume":"2437","author":"Alnasraui","year":"2022","journal-title":"AIP Conf. Proc."},{"key":"10.1016\/j.critrevonc.2026.105445_bib3","article-title":"A comprehensive review on MXene nanostructures for biosensing, imaging, and therapeutic systems. Sensing and Bio-Sensing","volume":"51","author":"Amani","year":"2026","journal-title":"Research"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105445_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/diseases13070207","article-title":"Hepatocellular Carcinoma: A Comprehensive Review","volume":"13","author":"Amin","year":"2025","journal-title":"Diseases"},{"key":"10.1016\/j.critrevonc.2026.105445_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106581","article-title":"Transarterial viroembolization improves the therapeutic efficacy of immune-excluded liver cancer: Three birds with one stone","volume":"187","author":"Cao","year":"2023","journal-title":"Pharmacol. Res."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105445_bib6","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1158\/1535-7163.MCT-22-0635","article-title":"An Oncolytic Poxvirus Encoding hNIS, Shows Antitumor Efficacy and Allows Tumor Imaging in a Liver Cancer Model","volume":"22","author":"Chaurasiya","year":"2023","journal-title":"Mol. Cancer Ther."},{"issue":"39","key":"10.1016\/j.critrevonc.2026.105445_bib7","article-title":"Viral-Directed Augmentation of Kupffer Cell Cross-Presentation Provokes Antitumor Immunity Against Liver Metastasis","volume":"12","author":"Chen","year":"2025","journal-title":"Adv. Sci. (Weinh. )"},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105445_bib8","doi-asserted-by":"crossref","first-page":"284","DOI":"10.14218\/JCTH.2021.00284","article-title":"Oncolytic Activity of Wild-type Newcastle Disease Virus HK84 Against Hepatocellular Carcinoma Associated with Activation of Type I Interferon Signaling","volume":"10","author":"Chen","year":"2022","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105445_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1186\/s12985-022-01779-1","article-title":"Oncolytic therapy with vaccinia virus carrying IL-24 for hepatocellular carcinoma","volume":"19","author":"Deng","year":"2022","journal-title":"Virol. J."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105445_bib10","article-title":"Advances in the treatment of hepatocellular carcinoma: An overview of the current and evolving therapeutic landscape for clinicians","volume":"75","author":"Dimitrios","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.critrevonc.2026.105445_bib11","article-title":"A conceptual exploration on the synergistic anti-tumor effects of high-order combination of OHSV2-DSTE(FAP5\/CD3), CAR-T cells, and immunotoxins in hepatocellular carcinoma","volume":"16","author":"Dong","year":"2025","journal-title":"Front. Immunol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105445_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics13070949","article-title":"Polymer Coated Oncolytic Adenovirus to Selectively Target Hepatocellular Carcinoma Cells","volume":"13","author":"Garofalo","year":"2021","journal-title":"Pharmaceutics"},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105445_bib13","first-page":"713","article-title":"Oncolytic Virus Senecavirus A Inhibits Hepatocellular Carcinoma Proliferation and Growth by Inducing Cell Cycle Arrest and Apoptosis","volume":"12","author":"Gong","year":"2024","journal-title":"J. Clin. Transl. Hepatol."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105445_bib14","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/j.ymthe.2023.04.006","article-title":"Safety and dose escalation of the targeted oncolytic adenovirus OBP-301 for refractory advanced liver cancer: Phase I clinical trial","volume":"31","author":"Heo","year":"2023","journal-title":"Mol. Ther."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105445_bib15","doi-asserted-by":"crossref","DOI":"10.3390\/v18040461","article-title":"Oncolytic Virotherapy and Immunogenic Cell Death: Mechanisms, Platforms, and Clinical Translation","volume":"18","author":"Inoue","year":"2026","journal-title":"Viruses"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105445_bib16","doi-asserted-by":"crossref","DOI":"10.3390\/md20060378","article-title":"Oncolytic Vaccinia Virus Harboring Aphrocallistes vastus Lectin Inhibits the Growth of Hepatocellular Carcinoma Cells","volume":"20","author":"Jiang","year":"2022","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.critrevonc.2026.105445_bib17","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2025.1623877","article-title":"The combination treatment of oncolytic adenovirus H101 with transcatheter arterial embolization sequential thermal ablation for hepatocellular carcinoma: a retrospective study","volume":"15","author":"Jing","year":"2025","journal-title":"Front. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105445_bib18","doi-asserted-by":"crossref","DOI":"10.1007\/s12668-026-02492-x","article-title":"Harnessing Nanoparticles to Enhance Therapeutic Efficacy in Oral Cancer Management","author":"Kamyab","year":"2026","journal-title":"BioNanoScience"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105445_bib19","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41417-025-00901-z","article-title":"Single-cell profiling of peripheral blood mononuclear cells from patients treated with oncolytic adenovirus TILT-123 reveals baseline immune status as a predictor of therapy outcomes","volume":"32","author":"Kudling","year":"2025","journal-title":"Cancer Gene Ther."},{"issue":"5-6","key":"10.1016\/j.critrevonc.2026.105445_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1089\/hum.2021.167","article-title":"Therapeutic Efficacy of an Oncolytic Influenza Virus Carrying an Antibody Against Programmed Cell Death 1 in Hepatocellular Carcinoma","volume":"33","author":"Lei","year":"2022","journal-title":"Hum. Gene Ther."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105445_bib21","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/cbin.11559","article-title":"A recombinant influenza virus with a CTLA4-specific scFv inhibits tumor growth in a mouse model","volume":"45","author":"Lei","year":"2021","journal-title":"Cell. Biol. Int."},{"issue":"1-2","key":"10.1016\/j.critrevonc.2026.105445_bib22","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1089\/hum.2022.206","article-title":"A Recombinant Oncolytic Influenza Virus Carrying GV1001 Triggers an Antitumor Immune Response","volume":"35","author":"Li","year":"2024","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.critrevonc.2026.105445_bib23","article-title":"The gamble between oncolytic virus therapy and IFN","volume":"13","author":"Li","year":"2022","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105445_bib24","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s13036-025-00582-0","article-title":"The construction of the gelatin methacrylate microneedle -encapsulated newcastle disease virus and its antitumor effect in hepatocellular carcinoma","volume":"19","author":"Li","year":"2025","journal-title":"J. Biol. Eng."},{"issue":"15","key":"10.1016\/j.critrevonc.2026.105445_bib25","doi-asserted-by":"crossref","first-page":"5452","DOI":"10.7150\/thno.87498","article-title":"Systemic delivery of glycosylated-PEG-masked oncolytic virus enhances targeting of antitumor immuno-virotherapy and modulates T and NK cell infiltration","volume":"13","author":"Liang","year":"2023","journal-title":"Theranostics"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105445_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/v15061294","article-title":"Combination of Oncolytic Measles Virus and Ursolic Acid Synergistically Induces Oncolysis of Hepatocellular Carcinoma Cells","volume":"15","author":"Liu","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.critrevonc.2026.105445_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2023.216485","article-title":"The spatial and single-cell analysis reveals remodeled immune microenvironment induced by synthetic oncolytic adenovirus treatment","volume":"581","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105445_bib28","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/cgt.2011.67","article-title":"Gene-viro-therapy targeting liver cancer by a dual-regulated oncolytic adenoviral vector harboring IL-24 and TRAIL","volume":"19","author":"Liu","year":"2012","journal-title":"Cancer Gene Ther."},{"key":"10.1016\/j.critrevonc.2026.105445_bib29","article-title":"Novel immune checkpoint inhibitor FilC\/PD-1 recombinant vaccinia virus inhibits hepatocellular carcinoma","volume":"12","author":"Luo","year":"2025","journal-title":"Front. Med. (Lausanne)"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105445_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.168033","article-title":"Engineered oncolytic herpes simplex virus expressing interleukin 12 suppresses tumorigenicity of hepatocellular carcinoma","volume":"1872","author":"Lv","year":"2026","journal-title":"Biochim. Biophys. Acta Mol. Basis Dis."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105445_bib31","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1002\/hep.32769","article-title":"Characterization of Morreton virus as an oncolytic virotherapy platform for liver cancers","volume":"77","author":"Nagalo","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.critrevonc.2026.105445_bib32","article-title":"Dielectrophoresis-based microfluidics for detection and separation of circulating tumor cells","volume":"9","author":"Najafipour","year":"2025","journal-title":"Sens. Actuators Rep."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105445_bib33","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1111\/cas.70063","article-title":"CDX2 Promoter-Controlled Oncolytic Adenovirus Suppresses Tumor Growth and Liver Metastasis of Colorectal Cancer","volume":"116","author":"Nakamura","year":"2025","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105445_bib34","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/cas.13492","article-title":"Third-generation oncolytic herpes simplex virus inhibits the growth of liver tumors in mice","volume":"109","author":"Nakatake","year":"2018","journal-title":"Cancer Sci."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105445_bib35","doi-asserted-by":"crossref","DOI":"10.3390\/cancers17030514","article-title":"Cross-Talk Between Tumor Cells and Stellate Cells Promotes Oncolytic VSV Activity in Intrahepatic Cholangiocarcinoma","volume":"17","author":"Neumeyer","year":"2025","journal-title":"Cancers (Basel)"},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105445_bib36","doi-asserted-by":"crossref","first-page":"18201","DOI":"10.1007\/s00432-023-05501-8","article-title":"Intratumoral delivery of a Tim-3 antibody-encoding oncolytic adenovirus engages an effective antitumor immune response in liver cancer","volume":"149","author":"Qiang","year":"2023","journal-title":"J. Cancer Res. Clin. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105445_bib37","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s43556-024-00202-1","article-title":"Oncolytic adenovirus encoding decorin and CD40 ligand inhibits tumor growth and liver metastasis via immune activation in murine colorectal tumor model","volume":"5","author":"Rong","year":"2024","journal-title":"Mol. Biomed."},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105445_bib38","first-page":"749","article-title":"Folated-nanocarrier for paclitaxel drug delivery in leukemia cancer therapy","volume":"10","author":"Sharafaldin Al-Musawi","year":"2018","journal-title":"J. Pharm. Sci. Res."},{"issue":"8062","key":"10.1016\/j.critrevonc.2026.105445_bib39","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41586-025-08717-5","article-title":"Oncolytic virus VG161 in refractory hepatocellular carcinoma","volume":"641","author":"Shen","year":"2025","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.critrevonc.2026.105445_bib40","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25137195","article-title":"Oncolytic Activity of Sindbis Virus with the Help of GM-CSF in Hepatocellular Carcinoma","volume":"25","author":"Shi","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2026.105445_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110323","article-title":"A recombinant oncolytic influenza virus expressing a PD-L1 antibody induces CD8(+) T-cell activation via the cGas-STING pathway in mice with hepatocellular carcinoma","volume":"120","author":"Sun","year":"2023","journal-title":"Int. Immunopharmacol."},{"issue":"12","key":"10.1016\/j.critrevonc.2026.105445_bib42","doi-asserted-by":"crossref","DOI":"10.3390\/v17121636","article-title":"Apoptin-Armed Oncolytic Adenovirus Triggers Apoptosis and Inhibits Proliferation, Migration, Invasion, and Stemness of Hepatocellular Carcinoma Hep3B Cells","volume":"17","author":"Sun","year":"2025","journal-title":"Viruses"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105445_bib43","article-title":"Enhancing immune response and survival in hepatocellular carcinoma with novel oncolytic Jurona virus and immune checkpoint blockade","volume":"32","author":"Tesfay","year":"2024","journal-title":"Mol. Ther. Oncol."},{"issue":"5","key":"10.1016\/j.critrevonc.2026.105445_bib44","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0322307","article-title":"Transcriptome insights into newcastle disease virus-mediated eradication of cholangiocarcinoma cells","volume":"20","author":"Thanyaphoo","year":"2025","journal-title":"PLoS. One"},{"key":"10.1016\/j.critrevonc.2026.105445_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.materresbull.2025.113927","article-title":"Advances and prospects of carbon polymer dots synthesis for chemical, biological, and therapeutic applications: A comprehensive review","volume":"196","author":"Thomas","year":"2026","journal-title":"Mater. Res. Bull."},{"issue":"0","key":"10.1016\/j.critrevonc.2026.105445_bib46","article-title":"Viral warfare: unleashing engineered oncolytic viruses to outsmart cancer's defenses","volume":"16","author":"Tolulope O","year":"2025","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105445_bib47","article-title":"Oncolytic virus V937 in combination with PD-1 blockade therapy to target immunologically quiescent liver and colorectal cancer","volume":"32","author":"Tran","year":"2024","journal-title":"Mol. Ther. Oncol."},{"issue":"3","key":"10.1016\/j.critrevonc.2026.105445_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.23677","article-title":"Luteolin enhances the antitumor efficacy of oncolytic vaccinia virus that harbors IL-24 gene in liver cancer cells","volume":"35","author":"Wang","year":"2021","journal-title":"J. Clin. Lab. Anal."},{"issue":"8","key":"10.1016\/j.critrevonc.2026.105445_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/md23080297","article-title":"An Oncolytic Vaccinia Virus Expressing Aphrocallistes vastus Lectin Modulates Hepatocellular Carcinoma Metabolism via ACSS2\/TFEB-Mediated Autophagy and Lipid Accumulation","volume":"23","author":"Wang","year":"2025","journal-title":"Mar. Drugs"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105445_bib50","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1093\/abbs\/gmab048","article-title":"An oncolytic adenovirus delivering TSLC1 inhibits Wnt signaling pathway and tumor growth in SMMC-7721 xenograft mice model","volume":"53","author":"Wang","year":"2021","journal-title":"Acta Biochim. Biophys. Sin. (Shanghai)"},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105445_bib51","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1158\/1078-0432.CCR-24-2498","article-title":"A Phase I Clinical Trial of Intrahepatic Artery Delivery of TG6002 in Combination with Oral 5-Fluorocytosine in Patients with Liver-Dominant Metastatic Colorectal Cancer","volume":"31","author":"West","year":"2025","journal-title":"Clin. Cancer Res."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105445_bib52","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.21037\/jgo-21-792","article-title":"Effects of recombinant human adenovirus type 5 combined with transarterial chemoembolization on postoperative metastasis and recurrence of hepatocellular carcinoma patients","volume":"12","author":"Wu","year":"2021","journal-title":"J. Gastrointest. Oncol."},{"key":"10.1016\/j.critrevonc.2026.105445_bib53","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2024.112305","article-title":"Oncolytic Newcastle disease virus carrying the IL24 gene exerts antitumor effects by inhibiting tumor growth and vascular sprouting","volume":"136","author":"Wu","year":"2024","journal-title":"Int. Immunopharmacol."},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105445_bib54","doi-asserted-by":"crossref","DOI":"10.3390\/md17060363","article-title":"Oncolytic Vaccinia Virus Expressing Aphrocallistes vastus Lectin as a Cancer Therapeutic Agent","volume":"17","author":"Wu","year":"2019","journal-title":"Mar. Drugs"},{"issue":"20","key":"10.1016\/j.critrevonc.2026.105445_bib55","doi-asserted-by":"crossref","first-page":"4288","DOI":"10.1158\/1078-0432.CCR-25-1620","article-title":"Clinical Evaluation of M1-c6v1 Oncolytic Virus Combined with Camrelizumab and Apatinib in Advanced Hepatocellular Carcinoma","volume":"31","author":"Xie","year":"2025","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2026.105445_bib56","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.trsl.2024.10.003","article-title":"Apolipoprotein A1-encoding recombinant adenovirus remodels cholesterol metabolism in tumors and the tumor microenvironment to inhibit hepatocellular carcinoma","volume":"275","author":"Xu","year":"2025","journal-title":"Transl. Res."},{"key":"10.1016\/j.critrevonc.2026.105445_bib57","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/JHC.S410703","article-title":"An Engineered Influenza a Virus Expressing the Co-Stimulator OX40L as an Oncolytic Agent Against Hepatocellular Carcinoma","volume":"11","author":"Yang","year":"2024","journal-title":"J. Hepatocell. Carcinoma"},{"key":"10.1016\/j.critrevonc.2026.105445_bib58","article-title":"Oncolytic Activity of a Chimeric Influenza A Virus Carrying a Human CTLA4 Antibody in Hepatocellular Carcinoma","volume":"12","author":"Yang","year":"2022","journal-title":"Front. Oncol."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105445_bib59","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41417-024-00853-w","article-title":"Oncolytic virus encoding 4-1BBL and IL15 enhances the efficacy of tumor-infiltrating lymphocyte adoptive therapy in HCC","volume":"32","author":"Ye","year":"2025","journal-title":"Cancer Gene Ther."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105445_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.esmoop.2024.102239","article-title":"The combination treatment of oncolytic adenovirus H101 with nivolumab for refractory advanced hepatocellular carcinoma: an open-label, single-arm, pilot study","volume":"9","author":"Yi","year":"2024","journal-title":"ESMO Open."},{"issue":"5-6","key":"10.1016\/j.critrevonc.2026.105445_bib61","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/hum.2023.150","article-title":"Combination Immunotherapy of Oncolytic Flu-Vectored Virus and Programmed Cell Death 1 Blockade Enhances Antitumor Activity in Hepatocellular Carcinoma","volume":"35","author":"Yu","year":"2024","journal-title":"Hum. Gene Ther."},{"issue":"16","key":"10.1016\/j.critrevonc.2026.105445_bib62","article-title":"Immunological Landscape and Molecular Therapeutic Targets of the Tumor Microenvironment in Hepatocellular Carcinoma","volume":"26","author":"Yusra","year":"2025","journal-title":"Int. J. Mol. Sci."},{"issue":"2","key":"10.1016\/j.critrevonc.2026.105445_bib63","doi-asserted-by":"crossref","DOI":"10.3390\/v17020162","article-title":"Ad6-Based GM-CSF Expressing Vector Displays Oncolytic and Immunostimulatory Effects in an Immunocompetent Syrian Hamster Model of Cholangiocarcinoma","volume":"17","author":"Zabelina","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.critrevonc.2026.105445_bib64","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.omto.2020.11.001","article-title":"Recombinant oncolytic adenovirus expressing a soluble PVR elicits long-term antitumor immune surveillance","volume":"20","author":"Zhang","year":"2021","journal-title":"Mol. Ther. Oncolytics"},{"issue":"6","key":"10.1016\/j.critrevonc.2026.105445_bib65","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1007\/s13402-021-00633-w","article-title":"Recombinant adenovirus expressing the fusion protein PD1PVR improves CD8(+) T cell-mediated antitumor efficacy with long-term tumor-specific immune surveillance in hepatocellular carcinoma","volume":"44","author":"Zhang","year":"2021","journal-title":"Cell Oncol (Dordr)"},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105445_bib66","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1038\/s41467-025-58407-z","article-title":"Lactobacillus acidophilus potentiates oncolytic virotherapy through modulating gut microbiota homeostasis in hepatocellular carcinoma","volume":"16","author":"Zhang","year":"2025","journal-title":"Nat. Commun."},{"issue":"7","key":"10.1016\/j.critrevonc.2026.105445_bib67","doi-asserted-by":"crossref","DOI":"10.3390\/md22070307","article-title":"ROS Induced by Aphrocallistes vastus Lectin Enhance Oncolytic Vaccinia Virus Replication and Induce Apoptosis in Hepatocellular Carcinoma Cells","volume":"22","author":"Zhang","year":"2024","journal-title":"Mar. Drugs"},{"issue":"11","key":"10.1016\/j.critrevonc.2026.105445_bib68","doi-asserted-by":"crossref","DOI":"10.3390\/md20110667","article-title":"Oncolytic Vaccinia Virus Carrying Aphrocallistes vastus Lectin (oncoVV-AVL) Enhances Inflammatory Response in Hepatocellular Carcinoma Cells","volume":"20","author":"Zheng","year":"2022","journal-title":"Mar. Drugs"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105445_bib69","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.cell.2024.12.010","article-title":"Hyperacute rejection-engineered oncolytic virus for interventional clinical trial in refractory cancer patients","volume":"188","author":"Zhong","year":"2025","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2026.105445_bib70","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24043823","article-title":"Effects of Oncolytic Vaccinia Viruses Harboring Different Marine Lectins on Hepatocellular Carcinoma Cells","volume":"24","author":"Zhou","year":"2023","journal-title":"Int. J. Mol. Sci."},{"issue":"1","key":"10.1016\/j.critrevonc.2026.105445_bib71","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/s42003-023-04983-z","article-title":"Navoximod modulates local HSV-1 replication to reshape tumor immune microenvironment for enhanced immunotherapy via an injectable hydrogel","volume":"6","author":"Zhuang","year":"2023","journal-title":"Commun. Biol."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282600332X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282600332X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T05:46:02Z","timestamp":1793943962000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084282600332X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":71,"alternative-id":["S104084282600332X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105445","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oncolytic virus-based immunotherapy for hepatocellular carcinoma: Strategies for enhanced efficacy and clinical application","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2026.105445","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"105445"}}